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E-mail address: lipid@biochem.iisc.ernet.in (R. RajThe regulation of phospholipid biosynthesis in Saccharomyces cerevisiae through cis-acting
upstream activating sequence inositol (UASino) and trans-acting elements, such as the INO2–INO4
complex and OPI1 by inositol supplementation in growth is thoroughly studied. In this study, we
provide evidence for the regulation of lipid biosynthesis by phosphatidylinositol-speciﬁc phospho-
lipase C (PLC) through UASino and the trans-acting elements. Gene expression analysis and radiola-
belling experiments demonstrated that the overexpression of rice PLC in yeast cells altered
phospholipid biosynthesis at the levels of transcriptional and enzyme activity. This is the ﬁrst report
implicating PLC in the direct regulation of lipid biosynthesis.
 2012 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Phospholipids are major constituents of structural assembly of
the cell and are integral to the growth, development and mainte-
nance of the organism. Among the phospholipids, phosphatidic
acid (PA) is an important intermediate in the biosynthesis of all
membrane glycerophospholipids and the storage lipid triacylglyc-
erol (TAG). PA is dephosphorylated to diacylglycerol (DAG), which
can subsequently be acylated to form TAG. For glycerophospholip-
ids biosynthesis, PA is converted to CDP-diacylglycerol (CDP-DG),
which is a liponucleotide intermediate that serves as a common
precursor for the de novo biosynthesis of phosphatidylinositol, car-
diolipin and phosphatidylcholine.chemical Societies. Published by E
lycerol; CDP-DAG, cytidined-
phate; Gro-3-P, glycerol-3-
l trisphosphate; IP4, inositol
6, inositol hexakisphosphate;
nositol; PI(4)P, phosphatidyl-
l 4,5-biphosphate; PI(3,5)P2,
ylcholine; PE, phosphatidyl-
lserine; PLC, phospholipase C
emistry, Indian Institute of
627.
asekharan).In Saccharomyces cerevisiae, phospholipid metabolism is known
to be altered by growth phase, by supplementation with inositol or
choline or by the depletion of nutrients such as zinc and nitrogen.
This regulation occurs through genetic and biochemical mecha-
nisms [1]. The genetic mechanism involves a cis-acting regulatory
sequence known as upstream activating sequence inositol (UASino),
which is found in the promoters of genes involved in lipid metab-
olism. This sequence element is recognised by the INO2–INO4
transcription activator protein complex, which binds to the se-
quence and activates the transcription of the downstream gene.
Another element that is involved in this regulation is the transcrip-
tional repressor OPI1. OPI1 is present in a complex with PA and
SCS2 at the endoplasmic reticulum or nuclear membranes. SCS2
is an integral membrane protein that binds to OPI1 through its
FFAT motif [2]. This binding is stabilised by PA. When OPI1 is
bound to these membranes, it cannot repress transcription, but
when PA levels drop, OPI1 is translocated into the nucleus and
binds to INO2 in the INO2–INO4 complex, thereby attenuating
transcriptional activation by this complex [1,3,4]. INO1, an inosi-
tol-3-phosphate synthase, is one of the most highly regulated of
the UASino-containing genes. The opi1D strain cannot repress the
expression of INO1, thereby leading to an inositol excretion pheno-
type, due to its constitutive expression of INO1.Moreover, the mis-
regulation of INO1 and other genes involved in lipid metabolism
result in inositol auxotrophy [5].lsevier B.V. All rights reserved.
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eukaryotic cells. PLC hydrolyses phosphatidylinositol-(4,5)-bis-
phosphate (PI(4,5)P2) to generate two second messengers, inositol
1,4,5-triphosphate (IP3) and DAG. In higher eukaryotes, IP3 triggers
an inﬂux of calcium from internal stores that leads to the modula-
tion of the Ca2+/calmodulin-dependent pathway [6], while DAG
activates the phospholipid and Ca2+-dependent protein kinase C
pathway [7]. S. cerevisiae encodes only one PLC, making it a good
model organism to study the role of PLC. PLC1 is not an essential
gene; plc1D is viable but has a number of phenotypes [8]. ARG82
is a bifunctional inositol polyphosphate kinase that converts IP3
to IP4 and IP5 to produce inositol polyphosphates that regulate
the activity of chromatin remodelling complexes [9,10]; moreover,
arg82D displays an inositol auxotrophic phenotype [5].
Using microarray, qRT-PCR and radiolabelling experiments, we
have demonstrated that phosphatidylinositol-speciﬁc PLC regu-
lates phospholipid biosynthesis through the transcriptional repres-
sion of UASino-containing genes. Taken together, these data suggest
that regulation by PLC appears to be a mechanism for controlling
the carbon ﬂux toward phospholipid and sphingolipid synthesis
by regulating either PA synthesis or the expression of genes in-
volved in the utilisation of PA.
2. Materials and methods
2.1. Strains, media and plasmids
The S. cerevisiae wild-type (BY4741; Mat a; his3D1; leu2D0;
met15D0; ura3D0; YPL268w::kanMX4) and plc1D Y07135 strains
were used. Yeast strains were grown either in YEPD (1% yeast ex-
tract, 2% Bacto Peptone, 2% dextrose) or synthetic minimal medium
containing 0.67% yeast nitrogen base (Difco) supplemented with
the appropriate amino acids, adenine and no uracil. The rice phos-
phatidylinositol-speciﬁc phospholipase AK064924 (rPLC) was
cloned in pYES2 (Invitrogen), a galactose-inducible yeast expres-
sion vector, as described previously [11]. Mutations in the active
site of rPLC-pYES2 (H178A, H132A) were generated by site-direc-
ted mutagenesis and conﬁrmed by DNA sequencing.
2.2. qRT-PCR and microarray
RNA was extracted using a hot-acid phenol method [12], sub-
jected to DNase digestion using Qiagen (Valencia, CA) DNase and
puriﬁed using a Qiagen RNeasy RNA extraction kit. The quality of
the RNA was analysed with an Agilent 2100 Bioanalyzer. Brieﬂy,
qRT-PCR was performed with Brilliant II SYBR Green QRT-PCR and
AfﬁnityScript 2-Step Master Mix with 1 lg of RNA and 4 lM of pri-
mer according to the manufacturer’s instructions. Some primer se-
quences were taken from Feddersen et al. (2007) [13] and other are
mention in Supplementary data, Table S1. The level of targetmRNAs
was normalised to the level of the ACT1 gene (actin) using the
2DDCTmethod [14]. The efﬁciencies and speciﬁcity of the primers
were tested with dilution experiments and melting curves, respec-
tively. The samples for gene expression were labelled using an Agi-
lent Quick-Amp Labeling Kit. Aliquots of the control and test
samples (500 ng each) were incubated with reverse transcription
mix at 40 C and converted to double-stranded cDNA with oligo-
dT priming using a T7 polymerase promoter. Double-stranded cDNA
was used as a template for cRNA generation. Next, cRNAwas gener-
ated by in vitro transcription, and the dye Cy3 CTP (Agilent) was
incorporated during this step. The cDNA synthesis and in vitro tran-
scription steps were carried out at 40 C. Labelled cRNA was
cleaned, and its quality was assessed for yield and speciﬁc activity.
The labelled cRNA samples were hybridised onto a S. cerevisiae
8  15k AMADID: 16333 Array. The Cy3-labelled sample (600 ng)was fragmented and hybridised. Fragmentation of the labelled
cRNA and hybridisation were performed using the Agilent Gene
Expression Hybridisation kit. Hybridisation was carried out in Agi-
lent SureHyb Chambers at 65 C for 16 h. The hybridised slides
were washed using Agilent Gene Expression wash buffers and
scanned using the Microarray Scanner at 5 lm resolution. Data
were extracted from the images using Feature Extraction software
v. 10.5.1.1.
The extracted data were analysed using GeneSpring GX v11
software. Normalisation was conducted in GeneSpring GX using
percentile shift normalisation in which the locations of all spot
intensities in an array were adjusted. This normalisation treats
each column in an experiment independently and computes the
percentile of the expression values for the array across all spots
(where n has a range from 0 to 100 and n = 75 is the median).
The programme subsequently subtracts this value from the expres-
sion value of each entity and normalises it to the value of a speciﬁc
control sample.
2.3. Labelling of phospholipids
S. cerevisiae BY4741 cells transformed with the rPLC-pYES2 and
pYES2 constructs were labelled with [32P] orthophosphate
(50 lCi/ml yeast nitrogen base (YNB) -Ura + 2% dextrose) at 30 C
at 200 rpm for 24 h. The cells were harvested by centrifugation,
and the cell pelletwaswashed twicewithwater. The cellswere then
allowed to grow on the same medium without radiolabel but with
2% galactose. After 3 h of galactose induction, each culture was di-
vided into two samples and subjected to glass bead lysis; one sam-
ple was subjected to lipid extraction (unincubated), and the other
was incubated at 30 C for 45 min in lysis buffer followed by lipid
extraction (incubated). The lipids were extracted in chloroform
from the lysate by vortexing it with 400 ll of a 1:2:1 (v/v) chloro-
form:methanol:2% H3PO4 mixture and using centrifugation to iso-
late the lipid-containing chloroform layer. The extracted lipids
were separated by two dimensional silica-TLC using chloro-
form:methanol:ammonia (65:25:5, v/v) as the ﬁrst dimension and
chloroform:methanol:acetone:acetic acid:water (50:10:20:15:5,
v/v) as the second dimension. The TLCs were phosphor-imaged,
and the spots corresponding to PC and PEwere scraped and counted
in a liquid scintillation counter.
3. Results
3.1. Gene expression analysis
To analyse the effects of rPLC overexpression on genome-wide
gene expression, the mRNA abundance of yeast cells overexpress-
ing rPLC-pYES2 was compared with vector control by microarray.
In this study, two biological replicates were conducted, consisting
of 2 and 5 h galactose-induced cells. The INO1 gene showed a 5.6-
and 4.43-fold decrease in 2 and 5 h induced cells, respectively, and
the expression of other UNAINO-containing genes was also de-
creased. The microarray data is deposited in NCBI’s Gene Expres-
sion Omnibus (GEO; http://www.ncbi.nlm.nih.gov/geo/query/
acc.cgi?acc=GSE35677) and is accessible through accession num-
ber GSE35677. The fold changes observed for certain UNAINO-con-
taining genes and other phospholipid biosynthesis-related genes
are summarised in Table 1. The microarray results were conﬁrmed
by qRT-PCR analyses in which the mRNA levels were normalised to
ACT1 mRNA levels. The mRNA expression analysis of rPLC over-
expressing cells showed a 13.9- and 6.7-fold decrease compared
to the vector control after 2 and 5 h inductions, respectively
(Fig. 1A). The difference between the value of microarray and
qRT-PCR is accounted by higher expression of rPLC in the cells
Table 1
Gene regulation upon rPLC overexpression. Fold change values upon overexpression
of rPLC, as determined by microarray. Negative values indicate downregulation.
Gene name 2 h Induction 5 h Induction
CDS1 1.02605 0.13816
CHO1 1.45248 1.01372
CHO2 1.2211 0.43538
CKI1 2.00744 0.26192
CPT1 1.17354 2.43639
EKI1 0.18581 0.59638
EPT1 1.03268 0.79447
INM1 4.46715 0.79012
INO1 5.62996 4.43988
ARG82 1.22085 0.57714
ITR1 1.49591 1.12422
OPI3 0.531084 0.31807
PIS1 1.57655 2.53941
PSD1 2.72814 0.080441
HNM1 2.002 3.495
LAC1 2.678 1.756
LCB2 2.463 3.707
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levels were downregulated by 4.7-, 4.1- and 3.8-fold, respectively
(Fig. 1B). We further accesses the transcription levels of CPT1,
INM1, ITR1, PIS1, LAC1 and LCB1 and were found to be downregu-
lated by 2.3-, 4.8-, 1.6-, 2.1-, 3.5- and 3.3-fold respectivelyFig. 1. Transcriptional analysis by qRT-PCR. All transcription levels are normalised to AC
pYES2) compared to vector control (pYES2) at 2 and 5 h after induction. (B) Changes in m
levels in a plc1D strain containing pYES2, a plc1D strain containing rPLC-pYES2 and a plc1
that in wild-type transformed with vector alone (pYES2) and induced for 3 h. (D) Fold cha
strain. The data represent means ± SD from at least three different experiments.(Supplementary data, Fig. S2). The fold difference was calculated
by comparing the expression in rPLC-pYES2 cells with that in
pYES2 cells. The changes in the expression levels of certain genes
upon PLC1 deletion were also studied by qRT-PCR. The INO1 tran-
script level in plc1D strains was 41.3-fold higher than that in
wild-type (Fig. 1C). This increase was abolished by the overexpres-
sion of rice PLC but not by its active site mutant (Fig. 1C). In com-
parison to wild-type strain, the transcription levels of CHO1, CHO2,
OLE1, ADR1 and SPG4 in the plc1D strain were increased by 5.7-,
3.6-, 8.7-, 3.8- and 24.2-fold respectively.
3.2. Labelling of phospholipids
The [32P] orthophosphate-labelled cells harbouring rPLC-pYES2
and pYES2 plasmids were induced with 2% galactose. The unincu-
bated sample represents initial levels of PE and PC were as incu-
bated sample represent the change in PE and PC levels and the
difference in both is net phospholipid synthesis. The difference be-
tween the levels of PE and PC in rPLC-pYES2 unincubated and incu-
bated was minor, suggesting low PE and PC synthetic capacity. In
contrast, a drastic difference in the levels of PE and PC was noted
for the cells harbouring the vector alone after incubation compared
to unincubated samples (Fig. 2A). The increase in the levels of PE and
PC in pYES2 represents the normal state of phospholipid biosynthe-
sis. The expression of rPLC decreased the rate of phospholipid syn-
thesis relative to the pYES2-containing cells. Fig. 2B shows theT1 (actin) transcription. (A) INO1 mRNA level in rPLC-expressing yeast cells (rPLC-
RNA levels in cells expressing rPLC compared to vector control. (C) The INO1 mRNA
D strain containing mutant rPLC (rPLC-pYES2; H178A, H132A mutant) compared to
nge in transcriptional level of genes in the plc1D strain, as compared to the wild-type
Fig. 2. [32P] Orthophosphate incorporation into lipids in rPLC-overexpressing yeast cells. Cells were transformed with rPLC-pYES2 or pYES2 and labelled with 50 lCi/ml 32P-
orthophosphate in YNB (yeast nitrogen base) -Ura + 2% dextrose medium for 24 h. The cells were harvested by centrifugation, washed twice with sterile water and allowed to
grow on the same medium containing 2% galactose without label. After 3 h of incubation, each culture was divided into two samples, each of which was subjected to glass
bead lysis. One sample was used for lipid extraction immediately, and the other was incubated at 30 C for 45 min prior to lipid extraction. (A) Two-dimensional-TLC showing
the separation of phospholipids, as visualised by phosphorimaging. PC is indicated by an asterisk while PE is indicated by an arrowhead (B) A graph showing the percentage
increase after incubation in radioactivity in PC and PE for rPLC-pYES2 and pYES2.
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ing cells. The percent increase in PE and PC for pYES2-transformed
cells after incubation was 150 and 283.3, respectively, whereas for
rPLC-pYES2-transformed cells, the percent increase was 5.4% and
15.3% respectively. The PS and other phospholipid including lysoli-
pids as seen in Fig. 1A are either utilised for PE and PC synthesis or
might have being degraded after incubation.
4. Discussion
We have demonstrated by microarray and qRT-PCR analyses
that INO1 and other phospholipid biosynthetic genes are repressedupon the overexpression of PLC. A 41-fold upregulation of INO1
transcripts was observed in the plc1D strain, which was consistent
with microarray analyses in an earlier report [15]. When the rice
PLC was overexpressed in the plc1D strain, there was a drastic de-
crease in INO1 transcript levels, whereas the overexpression of an
active-site mutant of rice PLC caused no such decrease. Also,
qRT-PCR analysis demonstrated the upregulation of CHO1, CHO2,
OLE1, ADR1 and SPG4 genes in the plc1D strain, further supporting
our observations. In an earlier report, it was shown that the OLE1
gene was regulated by inositol and choline through the low-oxy-
gen response element LORE; that study also demonstrated that
OLE1 is an INO2–INO4 target gene [16]. ADR1 and SPG4 expression
Fig. 3. Model for inositol auxotrophy caused by the repression of Ino1. PLC1 produces the secondary messenger IP3, which regulates phospholipid synthesising genes
containing UASINO. Mutations in genes indicated in italics (Red) causes inositol auxotrophy.
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repression of phospholipid biosynthetic genes at the mRNA level,
we also demonstrated a decrease in phospholipid biosynthesis in
rPLC-overexpressing cells compared to vector controls. In light of
these results, it is possible that the regulation of UNAINO-contain-
ing genes by the INO2–INO4 complex and OPI1 is not a mere reg-
ulation through a phospholipid precursor. Rather, this regulation
appears to be an overall regulation of lipid biosynthesis in response
to PLC activation. The repression of UNAINO-containing genes is
considered to be a mechanism for preferentially synthesising large
amounts of PI by inhibiting PS synthase activity, thereby making
the substrate available for PI synthase [17], which leads to a de-
crease in the biosynthesis of other phospholipids. However, several
observations contradict this hypothesis. For example, inositol sup-
plementation causes the repression of CDS1 [18] and ITR1 [16].
CDS1 synthesises CDP-DAG, which is an essential intermediate in
PI synthesis. Moreover, ITR1, which encodes inositol permease, is
also repressed, contradicting the notion that exogenous inositol
supplementation favours PI synthesis as a way to preferentially
utilise inositol. The marked differences between PLC overexpres-
sion and inositol supplementation are in the expression of PIS1
(PI-synthase) and INM1 (inositol monophosphatase), which are
upregulated by inositol addition [19] but were repressed upon rice
PLC overexpression (Table 1). Because both PIS1 and INM1 contain
the UNAINO consensus sequence in their promoter regions [19], the
transcription of these genes should be repressed upon the addition
of exogenous inositol [4]. However, this repression was not ob-
served. Conversely, repression by PLC is consistent with the regu-
latory pattern of the INO2–INO4 activator complex and the OPI1
repressor [1]. Deletion mutants that showed an inositol auxotroph
phenotype [5] we have tried to explained few of them by a regula-
tory role performed by PLC (Fig. 3). Mutations in the inositol phos-
phate pathway will effectively cause an accumulation of IP3 due to
non-utilisation, which will result in the repression of INO1. ARG82
is an inositol polyphosphate multikinase and a key enzyme in
quenching IP3 signalling. The arg82D strain was reported to have
reduced INO1 expression [9], an observation that further supports
our hypothesis. The mutations in the ceramide and sphingolipid
pathways shown in Fig. 3 will effectively result in the non-utilisa-
tion of PI and elevated PIP2 synthesis, which produces more IP3
upon stimulation by PLC. In the case of the phosphoinositide path-
way, a mutation in fab1 causes an increase in the PI(4,5)P2 level,
due to a failure to synthesise PI(3,5)P2, which, in turn, results inhigh IP3 production upon the stimulation of PLC. The deletion of
sac1 (encoding a PI(4,5)P2 5-phosphatase) should have reduce
INO1 expression by increasing the PI(4,5)P2 concentration through
a failure to hydrolyse its precursor, PI(4)P, but this reduction was
not observed, as described previously by Rivas et al. [20]. Interest-
ingly, Hughes et al. [21] observed that PI(4,5)P2 levels decreased in
sac1D, contrary to expectations, which also explains the observed
absence of change in INO1 expression.
We have also observed a downregulation of LAC1 (sphingolipid
biosynthesis) and LCB2 (ceramide biosynthesis) upon the overex-
pressionof PLC (Table 1, Supplementarydata, Fig. S2). The regulation
of phospholipid biosynthesis by PLC activation appears to be a
mechanism to siphon glucose, glycerol and fatty acids toward
processes other than phospholipid or sphingolipid and ceramide
biosynthesis. Under stress or conditions of limited glucose availabil-
ity, the synthesis of PI or other phospholipids is not essential. Thus, it
would be beneﬁcial to repress the INO1 gene (resulting in reduced
utilisation of glucose-6-P) together with other lipid biosynthetic
genes that utilise fatty acids and glycerol. PA is a keymetabolite that
connects glycolytic intermediates glycerol-3-phosphate or dihy-
droxyacetone phosphate with glycerolipid biosynthesis [22]. The
decreased levels of PA act as a signal under limiting amounts of glu-
cose or glycerol, which results in the repression of UNAINO-contain-
ing phospholipid biosynthetic genes through theOPI1 repressor.We
propose that signal produced by PLC causes the downregulation of
phospholipid, sphingolipid and ceramide (Table 1) biosynthesis
genes under stressful conditions, including nutrient deprivation. It
makes sense for cells to reduce synthesis of phospholipid, sphingo-
lipid and ceramide when the conditions are unfavourable for
growth, since these lipids are required in actively dividing cells. This
report is the ﬁrst to implicate IP3 in the regulation of cell physiology
unrelated to its activation of IP3-sensitive calcium channels. The PLC
acts as amodulator indeterminingcarbonﬂux, it causes a temporary
shift in lipid metabolism in accordance to the need of the cell.Acknowledgments
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